IP Library › Granted Patent US 12,478,730
Granted Patent B2
US 12,478,730 · App. 18/616,082 · Granted Nov 25, 2025

Simultaneous infusion and blood collection devices

Inventors: Benjamin W. Close (Brazil, IN); Thomas A. Hall, III (Lexington, TX)
Assignee: MEDTG, LLC
A61M5/16804A61B5/150351A61B5/150946A61B5/150992A61B2503/40A61M2250/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,730
App. No.
18/616,082
Granted
Nov 25, 2025
Kind
B2
Abstract

A device for the uninterrupted administration of fluid to an animal body during a draw of bodily fluid, e.g., blood from a blood vessel, is disclosed. A first fluid channel is configured to selectively transport IV fluid to an animal body and to draw a bodily fluid from the blood vessel via a catheter. A sealing member for sealing a blood draw port defines a concave surface on a first end. An outlet connector is configured to connect to a catheter to the first fluid channel and defines a concave distal end. An IV fluid inlet fluidly connected to an IV infusion lumen and configured for fluidic connection to an IV fluid source and uninterrupted delivery of IV fluid to the blood vessel. A valve member selectively provides a fluidic connection between the outlet connector and the IV fluid inlet, thereby selectively alternating between blood collection and IV fluid delivery.

Claims (29)

1 . An infusion and blood collection apparatus for use with a catheter having a distal end configured for insertion into a blood vessel, an IV fluid source, and a vacuum collection device providing a predetermined maximum vacuum pressure, the apparatus comprising:

an IV infusion lumen attachable to the catheter and defining a distal end, the IV infusion lumen configured for insertion into the blood vessel with the distal end of the IV infusion lumen extending a specified distance beyond the distal end of the catheter;

an IV fluid inlet fluidly connected to the IV infusion lumen and configured for fluidic connection to the IV fluid source and uninterrupted delivery of IV fluid to the blood vessel;

a draw port configured for fluidic connection to a blood collection channel, the draw port also configured for fluidic connection to the vacuum collection device;

an elastomeric seal for sealing the draw port, the elastomeric seal configured to receive therethrough a portion of the vacuum collection device;

an outlet connector configured for fluidic connection to the catheter; and

a valve member selectively providing a fluidic connection between the outlet connector and the IV fluid inlet, thereby selectively alternating between blood collection and IV fluid delivery.

2 . The infusion and blood collection apparatus of claim 1 , wherein:

the outlet connector defines a concave distal end surface;

the concave distal end surface is configured for fluidic connection with the catheter; and

a maximum depth of the concave distal end surface is out of alignment with a center of the outlet connector to create a fluid flow pattern that removes residual bodily fluid remaining at the concave distal end surface after the infusion and blood collection apparatus transitions from drawing bodily fluid from the blood vessel through the catheter to administering the IV fluid to the blood vessel through catheter.

3 . The infusion and blood collection apparatus of claim 1 , further comprising:

a passive fluid flow restriction device configured and sized to limit a flow rate of blood drawn through the distal end of the catheter by the predetermined maximum vacuum pressure of the vacuum collection device to a preselected flow rate; and

wherein the passive fluid flow restriction device is configured such that the preselected flow rate prevents IV fluid exiting the distal end of the IV infusion lumen from entering the distal end of the catheter when the catheter and the IV infusion lumen are inserted into the blood vessel, the IV fluid inlet is fluidly connected to the IV fluid source, and the draw port is fluidly connected to the vacuum collection device.

4 . The infusion and blood collection apparatus of claim 3 , wherein the passive fluid flow restriction device defines an internal cross-section sized so that the preselected flow rate is 30 ml/min or less.

5 . The infusion and blood collection apparatus of claim 3 , wherein the passive fluid flow restriction device defines an internal cross-section sized so that the preselected flow rate is 15 ml/min or less.

6 . The infusion and blood collection apparatus of claim 3 , wherein the specified distance is at least 10 mm.

7 . The infusion and blood collection apparatus of claim 3 , wherein the passive fluid flow restriction device includes a section of reduced internal cross-section for blood draw flow between the distal end of the catheter and the draw port.

8 . The infusion and blood collection apparatus of claim 3 , wherein the passive fluid flow restriction device comprises a length of 24-gauge stainless steel hypodermic round tubing.

9 . The infusion and blood collection apparatus of claim 3 , further comprising a blood collection component that includes the passive fluid flow restriction device, and wherein at least a portion of the passive fluid flow restriction device extends within the draw port.

10 . The infusion and blood collection apparatus of claim 9 , wherein the at least a portion of the passive fluid flow restriction device is configured to fluidly couple the vacuum collection device to the draw port.

11 . The infusion and blood collection apparatus of claim 3 , wherein the draw port is configured to couple with the vacuum collection device.

12 . The infusion and blood collection apparatus of claim 3 , wherein the passive fluid flow restriction device is sized to provide a volume flow rate of 30 ml/min or less when the predetermined maximum vacuum pressure of the vacuum collection device is 700 mmHg.

13 . The infusion and blood collection apparatus of claim 3 , wherein:

the outlet connector defines a concave distal end surface;

the concave distal end surface is configured for fluidic connection with the catheter; and

a maximum depth of the concave distal end surface is out of alignment with a center of the outlet connector to create a fluid flow pattern that removes residual bodily fluid remaining at the concave distal end surface after the infusion and blood collection apparatus transitions from drawing bodily fluid from the blood vessel through the catheter to administering the IV fluid to the blood vessel through catheter.

14 . The infusion and blood collection apparatus of claim 3 , wherein the draw port is configured to be entirely self-flushing of residue blood after a blood draw is completed and the draw port is selectively fluidly connected to the IV fluid inlet by the valve member.

15 . The infusion and blood collection apparatus of claim 3 , wherein the blood collection channel is configured to be entirely self-flushing of residue blood after a blood draw is completed and the blood collection channel is selectively fluidly connected to the IV fluid inlet by the valve member.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2025
From: CLOSE, BENJAMIN W.; HALL, THOMAS A., III
To: MEDTG, LLC
Reel/Frame 071506/0302 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 24, 2025
From: CLOSE, BENJAMIN W.
To: MEDTG, LLC
Reel/Frame 071506/0462 →
Continuity (8)
Continuation 18313896 · May 8, 2023
Continuation 18298280 · Apr 10, 2023
Continuation 17104899 · Nov 25, 2020
Continuation 15860487 · Jan 2, 2018
Continuation 14145717 · Dec 31, 2013
Provisional Application 62940596 · Nov 26, 2019
Provisional Application 61747815 · Dec 31, 2012
Related Publication 20240226430A1 · Jul 11, 2024
References Cited (129)
US 3490441A · Curtis · 1970 [cited by applicant]
US 3610226A · Albisser · 1971 [cited by applicant]
US 3841307A · Friedell · 1974 [cited by applicant]
US 3958562A · Hakim et al. · 1976 [cited by applicant]
US 3983864A · Sielaff et al. · 1976 [cited by applicant]
US 4014333A · McIntyre · 1977 [cited by applicant]
US 4072146A · Howes · 1978 [cited by applicant]
US 4098275A · Consalvo · 1978 [cited by applicant]
US 4160448A · Jackson · 1979 [cited by applicant]
US RE31873E · Howes · 1985 [cited by applicant]
US 4665927A · Daily · 1987 [cited by applicant]
US 4822343A · Beiser · 1989 [cited by examiner]
US 4865583A · Tu · 1989 [cited by applicant]
US 5013304A · Russell et al. · 1991 [cited by applicant]
US 5122129A · Olson et al. · 1992 [cited by applicant]
US 5165406A · Wong · 1992 [cited by applicant]
US 5193545A · Marsoner et al. · 1993 [cited by applicant]
US 5250066A · Lambert · 1993 [cited by applicant]
US 5290246A · Yamamoto et al. · 1994 [cited by applicant]
US 5312361A · Zadini et al. · 1994 [cited by applicant]
US 5364374A · Morrison et al. · 1994 [cited by applicant]
US 5374245A · Mahurkar · 1994 [cited by applicant]
US 5378230A · Mahurkar · 1995 [cited by applicant]
US 5395319A · Hirsch et al. · 1995 [cited by applicant]
US 5451206A · Young · 1995 [cited by applicant]
US 5568806A · Cheney, II et al. · 1996 [cited by applicant]
US 5607401A · Humphrey · 1997 [cited by applicant]
US 5620008A · Shinar · 1997 [cited by examiner]
US 5637399A · Yoshikawa et al. · 1997 [cited by applicant]
US 5846228A · Alexander · 1998 [cited by applicant]
US 5876366A · Dykstra et al. · 1999 [cited by applicant]
US 5891105A · Mahurkar · 1999 [cited by applicant]
US 5947953A · Ash et al. · 1999 [cited by applicant]
US 5951521A · Mastrototaro et al. · 1999 [cited by applicant]
US 5954701A · Matalon · 1999 [cited by applicant]
US 6032059A · Henning et al. · 2000 [cited by applicant]
US 6146354A · Beil · 2000 [cited by applicant]
US 6190371B1 · Maginot et al. · 2001 [cited by applicant]
US 6221058B1 · Kao et al. · 2001 [cited by applicant]
US 6228864B1 · Smith et al. · 2001 [cited by applicant]
US 6245079B1 · Nobles et al. · 2001 [cited by applicant]
US 6569117B1 · Ziv et al. · 2003 [cited by applicant]
US 6758835B2 · Close et al. · 2004 [cited by applicant]
US 7335182B1 · Hilaire · 2008 [cited by examiner]
US 8021319B2 · Delnevo · 2011 [cited by examiner]
US 8348844B2 · Kunjan et al. · 2013 [cited by applicant]
US 8364231B2 · Kamath et al. · 2013 [cited by applicant]
US 8366685B2 · Devgon · 2013 [cited by applicant]
US 9855386B2 · Close et al. · 2018 [cited by applicant]
US 10383605B2 · Niestroj-Pahl et al. · 2019 [cited by applicant]
US 11141545B2 · Anderson · 2021 [cited by examiner]
US 11623038B2 · Hall, III et al. · 2023 [cited by applicant]
US 11642458B2 · Close · 2023 [cited by applicant]
US 11938299B2 · Close · 2024 [cited by applicant]
US 20010001125A1 · Schulman et al. · 2001 [cited by applicant]
US 20010003991A1 · Sato et al. · 2001 [cited by applicant]
US 20010007932A1 · Kamen et al. · 2001 [cited by applicant]
US 20010009994A1 · Small et al. · 2001 [cited by applicant]
US 20010016715A1 · Mayer · 2001 [cited by examiner]
US 20010019019A1 · Nordman et al. · 2001 [cited by applicant]
US 20010020591A1 · Hasegawa et al. · 2001 [cited by applicant]
US 20010021429A1 · Nizuka et al. · 2001 [cited by applicant]
US 20010025157A1 · Kriesell · 2001 [cited by applicant]
US 20030149395A1 · Zawacki · 2003 [cited by applicant]
US 20040210162A1 · Wyatt et al. · 2004 [cited by applicant]
US 20040236286A1 · Klein · 2004 [cited by applicant]
US 20050027233A1 · Flaherty · 2005 [cited by examiner]
US 20060000432A1 · Yamamoto et al. · 2006 [cited by applicant]
US 20060189926A1 · Hall · 2006 [cited by examiner]
US 20070083091A1 · Sterling et al. · 2007 [cited by applicant]
US 20070179436A1 · Braig et al. · 2007 [cited by applicant]
US 20070219509A1 · Tashiro et al. · 2007 [cited by applicant]
US 20080200837A1 · Frazier et al. · 2008 [cited by applicant]
US 20080319346A1 · Crawford · 2008 [cited by examiner]
US 20090048576A1 · Robinson et al. · 2009 [cited by applicant]
US 20090124964A1 · Leach et al. · 2009 [cited by applicant]
US 20090178459A1 · Li · 2009 [cited by examiner]
US 20090259145A1 · Bartfeld · 2009 [cited by examiner]
US 20110009720A1 · Kunjan et al. · 2011 [cited by applicant]
US 20110160662A1 · Stout · 2011 [cited by examiner]
US 20110319728A1 · Petisce · 2011 [cited by examiner]
US 20120095369A1 · Teixeira et al. · 2012 [cited by applicant]
US 20120191010A1 · Cabot · 2012 [cited by applicant]
US 20120277627A1 · Devgon · 2012 [cited by examiner]
US 20120277630A1 · Devgon · 2012 [cited by applicant]
US 20130165868A1 · Isaacson · 2013 [cited by examiner]
US 20130178760A1 · Downie · 2013 [cited by examiner]
US 20140046214A1 · Devgon et al. · 2014 [cited by applicant]
US 20140207083A1 · Pessin · 2014 [cited by examiner]
US 20140276215A1 · Nelson · 2014 [cited by examiner]
US 20140364766A1 · Devgon et al. · 2014 [cited by applicant]
US 20150173663A1 · Teoh · 2015 [cited by examiner]
US 20150201963A1 · Snow · 2015 [cited by examiner]
US 20180140240A1 · Bullington · 2018 [cited by examiner]
US 20180214682A1 · Woehr · 2018 [cited by examiner]
US 20180304041A1 · Leeflang · 2018 [cited by examiner]
US 20190091462A1 · Bihlmaier et al. · 2019 [cited by applicant]
US 20190125236A1 · Hoan · 2019 [cited by examiner]
US 20190160275A1 · Funk et al. · 2019 [cited by applicant]
US 20190262599A1 · Nakagami · 2019 [cited by examiner]
US 20200078564A1 · Blanchard · 2020 [cited by examiner]
US 20200254195A1 · Nakagami · 2020 [cited by examiner]
US 20200352498A1 · Schuster et al. · 2020 [cited by applicant]
US 20210045688A1 · Komada · 2021 [cited by examiner]
US 20210113811A1 · Nakagami et al. · 2021 [cited by applicant]
US 20210116041A1 · Mermelshtein et al. · 2021 [cited by applicant]
US 20210138162A1 · Nakagami · 2021 [cited by examiner]
US 20210299344A1 · Urakabe · 2021 [cited by applicant]
US 20210389215A1 · Gao · 2021 [cited by examiner]
US 20220257919A1 · Damarati · 2022 [cited by examiner]
US 20230241313A1 · Close et al. · 2023 [cited by applicant]
CN 101573154A · 2009 [cited by applicant]
CN 101631498A · 2010 [cited by applicant]
CN 101678192A · 2010 [cited by applicant]
RU 2335302C2 · 2008 [cited by applicant]
WO 2008042625A2 · 2008 [cited by applicant]
WO 2012149109A2 · 2012 [cited by applicant]
WO 2013130254A1 · 2013 [cited by applicant]
Examination Report for Appl. No. CA 2,896,716 dated Aug. 21, 2019. [cited by applicant]
Examination Report for Appl. No. In 6068/DELNP/2015 (dated Jan. 9, 2020). [cited by applicant]
Extended European Search Report for EP 20892843.2 dated Nov. 3, 2023. [cited by applicant]
Office Action for Appl. No. CN 201380074068.8 (dated Aug. 18, 2016). [cited by applicant]
Office Action for Appl. No. CN 201380074068.8 (dated Jun. 28, 2017). [cited by applicant]
Office Action for Appl. No. EP 13867172.2 (dated Oct. 25, 2016). [cited by applicant]
Office Action for Appl. No. RU 2015129013 (dated Aug. 28, 2018). [cited by applicant]
Office Action for Appl. No. RU 2015129013 (dated Oct. 19, 2017). [cited by applicant]
Office Action for Appl. No. U.S. Appl. No. 18/298,280 (dated Nov. 18, 2024). [cited by applicant]
Written Opinion of the International Searching Authority and International Search Report for PCT/US2013/078538, dated Mar. 27, 2014. [cited by applicant]
Written Opinion of the International Searching Authority for PCT/US2020/062316 dated Feb. 17, 2021. [cited by applicant]